Target Name: CYBC1
NCBI ID: G79415
Other Name(s): Cytochrome b-245 chaperone 1, transcript variant 1 | CGD5 | essential for reactive oxygen species protein | Cytochrome b-245 chaperone 1 (isoform a) | Essential for reactive oxygen species protein | Uncharacterized protein C17orf62 | CYBC1_HUMAN | CYBC1 variant 1 | Eros | Cytochrome b-245 chaperone 1, transcript variant 2 | CYBC1 variant 2 | Cytochrome b-245 chaperone 1 | uncharacterized protein C17orf62 | C17orf62 | cytochrome b-245 chaperone 1

CYBC1: A Potential Drug Target for Cell Signaling and Disease

CYBC1, also known as Cytochrome b-245 chaperone 1, transcript variant 1, is a protein that plays a crucial role in cell signaling pathways. It is a member of the cytochrome P450 (CYP) superfamily, which is responsible for a wide range of cellular processes, including drug metabolism and excretion, as well as modulating gene expression. CYBC1 is expressed in various tissues and cells throughout the body, including the liver, pancreas, and gastrointestinal tract, and has been implicated in a number of diseases and drug responses . As a drug target, CYBC1 is a promising biomarker for the development of new therapies, and its study is of great interest to researchers.

CYBC1 is a 44kDa protein that is expressed in the cytoplasm of various cell types. It is a member of the CYP450 enzyme family, which is responsible for the production of a wide range of compounds, including drugs, toxins, and environmental pollutants. The CYP450 enzyme family is one of the most widely studied superfamilies in pharmacology, and its members are involved in a wide range of cellular processes, including drug metabolism, excretion, and signaling.

CYBC1 is involved in several cellular processes that are critical for proper cell function. One of its main functions is modulating the activity of other enzymes, such as CYP3A4 and CYP2C9. These enzymes are involved in the metabolism of a wide range of drugs, and CYBC1 plays a critical role in regulating their activity. It does this by interacting with the active site of these enzymes, where it can modulate the substrate binding sites and influence the rate of catalytic cycles.

Another function of CYBC1 is to regulate gene expression. It is a known regulator of the CYP450 gene, which encodes the enzymes that are involved in the CYP450 superfamily. CYBC1 can bind to the promoter region of the CYP450 gene and prevent it from being translated into RNA. This silences the gene, and as a result, it is not expressed in the cell. However, if the CYBC1 activity is inhibited, the CYP450 gene is transcribed and translated into RNA, leading to the production of CYP450 enzymes.

CYBC1 is also involved in the regulation of cellular signaling pathways. It is a known regulator of several intracellular signaling pathways, including the TGF-β pathway and the Wnt/FGF pathway. TGF-β is a well-known growth factor that regulates cellular growth , differentiation, and survival, and is involved in many diseases, including cancer, neurodegenerative diseases, and developmental disorders. The TGF-β pathway is a complex signaling pathway that is involved in the regulation of cellular processes that are critical for normal development and function . CYBC1 plays a critical role in the regulation of TGF-β signaling by modulating the activity of several transcription factors, including SMAD1 and STAT3.

In addition to its role in modulating gene expression and cellular signaling pathways, CYBC1 is also involved in the regulation of drug metabolism. It is a known regulator of drug metabolism pathways, including the metabolism of drugs associated with metabolism by CYP450 enzymes. CYBC1 can interact with CYP450 enzymes to modulate their activity, which can result in changes in drug metabolism rates and metabolism profiles. This has important implications for the development of new drugs and the assessment of drug responses.

CYBC1 is also a potential biomarker for the diagnosis and treatment of several diseases. Its involvement in the regulation of cellular processes makes it an attractive target for the development of new therapies. For example, inhibition of CYBC1 activity has been shown to have anti-inflammatory effects, and may be useful in the treatment of

Protein Name: Cytochrome B-245 Chaperone 1

Functions: Functions as a chaperone necessary for a stable expression of the CYBA and CYBB subunits of the cytochrome b-245 heterodimer (PubMed:30361506). Controls the phagocyte respiratory burst and is essential for innate immunity (By similarity)

More Common Targets

CYBRD1 | CYC1 | Cyclin | Cyclin A | Cyclin B | Cyclin D | Cyclin D2-CDK4 complex | Cyclin-dependent kinase | Cyclin-dependent kinase inhibitor | Cyclooxygenase (COX) | Cyclophilins | CYCS | CYCSP25 | CYCSP34 | CYCSP38 | CYCSP51 | CYCSP52 | CYCSP53 | CYCSP55 | CYFIP1 | CYFIP2 | CYGB | CYLC1 | CYLC2 | CYLD | CYLD-AS1 | CYMP | CYP11A1 | CYP11B1 | CYP11B2 | CYP17A1 | CYP19A1 | CYP1A1 | CYP1A2 | CYP1B1 | CYP1B1-AS1 | CYP20A1 | CYP21A1P | CYP21A2 | CYP24A1 | CYP26A1 | CYP26B1 | CYP26C1 | CYP27A1 | CYP27B1 | CYP27C1 | CYP2A13 | CYP2A6 | CYP2A7 | CYP2A7P1 | CYP2B6 | CYP2B7P | CYP2C18 | CYP2C19 | CYP2C61P | CYP2C8 | CYP2C9 | CYP2D6 | CYP2D7 | CYP2D8P | CYP2E1 | CYP2F1 | CYP2F2P | CYP2G1P | CYP2J2 | CYP2R1 | CYP2S1 | CYP2T1P | CYP2U1 | CYP2U1-AS1 | CYP2W1 | CYP39A1 | CYP3A4 | CYP3A43 | CYP3A5 | CYP3A51P | CYP3A7 | CYP3A7-CYP3A51P | CYP3AP2 | CYP46A1 | CYP4A11 | CYP4A22 | CYP4B1 | CYP4F11 | CYP4F12 | CYP4F2 | CYP4F22 | CYP4F26P | CYP4F29P | CYP4F3 | CYP4F30P | CYP4F34P | CYP4F35P | CYP4F59P | CYP4F62P | CYP4F8 | CYP4V2 | CYP4X1 | CYP4Z1 | CYP4Z2P